Ultrahuman Acquires viO HealthTech to Add OvuSense Ovulation Tech

Ultrahuman has acquired viO HealthTech and launched Cycle & Ovulation Pro for its Ultrahuman Ring AIR, integrating viO's clinically validated OvuSense ovulation-tracking algorithm into the ring using finger-based temperature sensing. viO's technology — developed over 15 years with FDA 510(k) clearance and CE Class IIa certifications — will be offered as a paid subscription across the US, UK, EU, Canada and Australia. The deal brings clinical-grade women's health capability to Ultrahuman's consumer wearable platform to improve cycle and ovulation insights.